Nothing Special   »   [go: up one dir, main page]

ES2196281T3 - Aplicacion de compuestos esteroides sustituidos en posicion 11 para lafabricacion de medicamentos con actividad estrogena disociada. - Google Patents

Aplicacion de compuestos esteroides sustituidos en posicion 11 para lafabricacion de medicamentos con actividad estrogena disociada.

Info

Publication number
ES2196281T3
ES2196281T3 ES97403115T ES97403115T ES2196281T3 ES 2196281 T3 ES2196281 T3 ES 2196281T3 ES 97403115 T ES97403115 T ES 97403115T ES 97403115 T ES97403115 T ES 97403115T ES 2196281 T3 ES2196281 T3 ES 2196281T3
Authority
ES
Spain
Prior art keywords
strogen
medicines
activity
manufacture
disposed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97403115T
Other languages
English (en)
Inventor
Yamina Bouali
Francois Nique
Daniel Philibert
Jean-Georges Teutsch
De Velde Patrick Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of ES2196281T3 publication Critical patent/ES2196281T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION TIENE POR OBJETO LA APLICACION DE COMPUESTOS ESTEROIDES DE FORMULA (I): EN LA CUAL N, R 1 , R 2 , X E Y SON COMO SE DEFINE EN LA DESCRIPCION, A LA FABRICACION DE MEDICAMENTOS DESTINADOS AL TRATAMIENTO HORMONAL SUSTITUTORIO DE LA MENOPAUSIA O LA PERIMENOPAUSIA; PRESENTAN ESCASA ACTIVIDAD ESTROGENICA EN EL TERRITORIO UTERINO.
ES97403115T 1996-12-23 1997-12-22 Aplicacion de compuestos esteroides sustituidos en posicion 11 para lafabricacion de medicamentos con actividad estrogena disociada. Expired - Lifetime ES2196281T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9615828A FR2757399B1 (fr) 1996-12-23 1996-12-23 Application de composes steroides substitues en 11 pour la fabrication de medicaments ayant une activite estrogene dissociee

Publications (1)

Publication Number Publication Date
ES2196281T3 true ES2196281T3 (es) 2003-12-16

Family

ID=9498982

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97403115T Expired - Lifetime ES2196281T3 (es) 1996-12-23 1997-12-22 Aplicacion de compuestos esteroides sustituidos en posicion 11 para lafabricacion de medicamentos con actividad estrogena disociada.

Country Status (7)

Country Link
US (2) US5981516A (es)
EP (1) EP0850647B1 (es)
JP (1) JP4263264B2 (es)
AT (1) ATE235243T1 (es)
DE (1) DE69720160T2 (es)
ES (1) ES2196281T3 (es)
FR (1) FR2757399B1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757519B1 (fr) * 1996-12-23 1999-06-11 Hoechst Marion Roussel Inc Steroides substitues en position 11, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
US6172052B1 (en) * 1998-12-04 2001-01-09 Research Triangle Institute 17β-acyl-17α-propynyl-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
DE19929715A1 (de) * 1999-06-24 2000-12-28 Schering Ag 11ß-langkettig-substituierte Estratriene, Verfahren zur Herstellung , pharmazeutische Präparate, die diese 11ß-langkettig-substituierten Estratriene enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
MX344497B (es) 2005-09-27 2016-12-19 Paradigm Spine Llc Dispositivos interespinales de estabilización vertebral.
US20080103116A1 (en) * 2006-11-01 2008-05-01 Jennings-Spring Barbara L Method of treatment and compositions of D-chiro inositol and phosphates thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2528434B1 (fr) * 1982-06-11 1985-07-19 Roussel Uclaf Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
US4978657A (en) * 1981-01-09 1990-12-18 Roussel Uclaf Novel 11β-substituted-19-nor-steroids
FR2640977A2 (en) * 1982-06-11 1990-06-29 Roussel Uclaf New position-11 substituted 19-norsteroids and their application as medicinal products.
FR2596395B1 (fr) * 1986-03-26 1989-05-26 Roussel Uclaf Nouveaux steroides comportant un cycle spirannique en position 17, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
FR2618783B1 (fr) * 1987-07-30 1991-02-01 Roussel Uclaf Nouveaux 17-aryle steroides, leurs procedes et des intermediaires de preparation comme medicaments et les compositions pharmaceutiques les renfermant
US4925816A (en) * 1987-08-29 1990-05-15 Ngk Insulators, Ltd. Novel solid solution, heat-resistant sintered body and method of producing the same
FR2620707B1 (fr) * 1987-09-18 1989-12-08 Roussel Uclaf Nouveaux steroides comportant un cycle spirannique a 3, 4 ou 6 chainons en position 17, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant

Also Published As

Publication number Publication date
DE69720160T2 (de) 2003-11-13
US5981516A (en) 1999-11-09
EP0850647B1 (fr) 2003-03-26
FR2757399A1 (fr) 1998-06-26
DE69720160D1 (de) 2003-04-30
EP0850647A1 (fr) 1998-07-01
FR2757399B1 (fr) 1999-12-17
ATE235243T1 (de) 2003-04-15
JPH10182466A (ja) 1998-07-07
JP4263264B2 (ja) 2009-05-13
US6011026A (en) 2000-01-04

Similar Documents

Publication Publication Date Title
BR9814747A (pt) Derivados pleuromutilina atuando comoantimicrobianos
ES2077948T3 (es) Preparacion para el cuidado externo de la piel.
GEP20022803B (en) Steroid Sulphatase Inhibitors
IL175398A0 (en) Steroidal compounds and pharmaceutical compositions containing them for treating oxidative stress and inflammation
GR3034650T3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
ES2196281T3 (es) Aplicacion de compuestos esteroides sustituidos en posicion 11 para lafabricacion de medicamentos con actividad estrogena disociada.
IL91047A (en) Zinc complexes for the treatment of free radical- induced diseases
ES2132101T3 (es) Procedimiento para la preparacion de un medicamento destinado a la administracion por via oral o topica en el tratamiento de leishmaniasis.
MY106314A (en) New tetrazole derivatives, process for their preparation and their use
HK66895A (en) Suppression of parathyroid hormone synthesis and secretion with vitamin D3 derivatives
ES2134313T3 (es) Utilizacion de derivados de pregnano para el tratamiento de tumores.
EP0451869A3 (en) Use of steroid derivatives in the treatment of endometriosis
IL150121A0 (en) Antipruritic agents for external use
GR3033882T3 (en) Use of aromatic steroids substituted in 3-position by a disubstituted aminoalkoxy chain for the manufacture of a medicament for the control of fertility, in particular male fertility.
EP0548558A3 (en) Compositions containing surfactants as potentiating agents for the treatment of mammalian diseases
TW280810B (es)
IT1131887B (it) Glicosidi antraciclinici
SE8205868D0 (sv) A titre de medicaments, certains derives de lŸacide 4-phenyl 4-oxo 2-butenoique et compositions les renfermant
DE69200365D1 (de) Pharmazeutische Zusammensetzung zur Verbesserung von Dysuria.
MX9302870A (es) Derivados de octahidronaftalenoxima para inhibicion de biosintesis de colesterol, su preparacion y uso.
SE7902867L (sv) Antikomplementera medel
ES2121058T3 (es) Compuestos antibioticos de carbapenem.
AU4804990A (en) Use of isocarbacyclins for preventing or treating organ diseases
AU628404B2 (en) Branched-chain alkyl esters of 2-(4-(2-piperidino-ethoxy)- benzoyl)-benzoic acid, processes for their preparation and their use as spasmolytic agents
CA2012978A1 (en) Treatment of hepatic diseases using fk 506 and related compounds